Pharma duo Glenmark & Cipla stocks to flag off; Top gainers & losers | Market Fatafat
Video description:
Glenmark Pharmaceuticals' share price surged 30 percent after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections. At the same time, Cipla's stock jumped by as much as 7 per cent to Rs 664.45 per unit after it announced the launch of remdesivir under its brand name Cipremi. The Life Insurance Corporation of India (abbreviated as LIC) is one of the top losers today. Watch to know the top gainers and losers on Market Fatafat with Mubina Kapasi. Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3 Subscribe Now To Our Network Channels :- Times Now : http://goo.gl/U9ibPb The NewsHour Debate : http://goo.gl/LfNgFF To Stay Updated Download the Times Now App :- Android Google Play : https://goo.gl/zJhWjC Apple App Store : https://goo.gl/d7QBQZ Social Media Links :- Twitter - http://goo.gl/hA0vDt Facebook - http://goo.gl/5Lr4mC G+ - http://goo.gl/hYxrmj Website - www.etnownews.com
via https://youtu.be/v0EAJq_p6Yg
We do not own the video this is just a player link and it could contain by other parties.
Watch youtube video here: the best video collection
No comments:
Post a Comment